Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 344

1.

In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.

Gill MM, Rao JU, Kaleem F, Hassan A, Khalid A, Anjum R.

Pak J Pharm Sci. 2013 Jan;26(1):7-10.

PMID:
23261721
2.

Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa.

Gill MM, Usman J, Kaleem F, Hassan A, Khalid A, Anjum R, Fahim Q.

J Coll Physicians Surg Pak. 2011 Sep;21(9):531-4. doi: 09.2011/JCPSP.531534.

PMID:
21914408
3.
4.

In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.

Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V.

J Med Assoc Thai. 2008 Oct;91 Suppl 3:S21-7.

PMID:
19255989
5.

In vitro activity of colistin against multidrug-resistant Pseudomonas aeruginosa isolates from patients in Songklanagarind Hospital, Thailand.

Tunyapanit W, Pruekprasert P, Laoprasopwattana K, Chelae S.

Southeast Asian J Trop Med Public Health. 2013 Mar;44(2):273-80.

PMID:
23691637
6.

[Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli].

Paluchowska P, SkaƂkowska M, Spelak A, Budak A.

Med Dosw Mikrobiol. 2012;64(1):45-53. Polish.

PMID:
22808729
8.

Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.

Somily AM, Absar MM, Arshad MZ, Al Aska AI, Shakoor ZA, Fatani AJ, Siddiqui YM, Murray TS.

Saudi Med J. 2012 Jul;33(7):750-5.

PMID:
22821309
9.

In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.

Vidaillac C, Benichou L, Duval RE.

Antimicrob Agents Chemother. 2012 Sep;56(9):4856-61. doi: 10.1128/AAC.05996-11. Epub 2012 Jul 2.

10.

Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula.

Bergen PJ, Forrest A, Bulitta JB, Tsuji BT, Sidjabat HE, Paterson DL, Li J, Nation RL.

Antimicrob Agents Chemother. 2011 Nov;55(11):5134-42. doi: 10.1128/AAC.05028-11. Epub 2011 Aug 29.

12.

Evaluation in vitro of the efficacy of colistin methanesulfonate against biofilm-forming multidrug-resistant Pseudomonas aeruginosa (MDRP).

Marumo K, Komukai D, Hirose M, Nakamura H, Tanaka H, Ugajin K, Nagashima G, Yoshimura A.

J Infect Chemother. 2013 Apr;19(2):348-51. doi: 10.1007/s10156-012-0456-x. Epub 2012 Aug 8.

PMID:
22872187
13.

The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.

Gailiene G, Pavilonis A, Kareiviene V.

Medicina (Kaunas). 2007;43(1):36-42.

14.

In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.

Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V.

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S95-100.

PMID:
22043760
15.
16.

Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.

McCracken M, Mataseje LF, Loo V, Walkty A, Adam HJ, Hoban DJ, Zhanel GG, Mulvey MR; Canadian Antimicrobial Resistance Alliance (CARA).

Diagn Microbiol Infect Dis. 2011 Mar;69(3):335-41. doi: 10.1016/j.diagmicrobio.2010.10.030.

PMID:
21353962
17.

Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.

van der Heijden IM, Levin AS, De Pedri EH, Fung L, Rossi F, Duboc G, Barone AA, Costa SF.

Ann Clin Microbiol Antimicrob. 2007 Aug 15;6:8.

19.

In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008.

Walkty A, DeCorby M, Nichol K, Karlowsky JA, Hoban DJ, Zhanel GG.

Antimicrob Agents Chemother. 2009 Nov;53(11):4924-6. doi: 10.1128/AAC.00786-09. Epub 2009 Aug 24.

20.

Colistin susceptibility testing by Etest and disk diffusion methods.

Galani I, Kontopidou F, Souli M, Rekatsina PD, Koratzanis E, Deliolanis J, Giamarellou H.

Int J Antimicrob Agents. 2008 May;31(5):434-9. doi: 10.1016/j.ijantimicag.2008.01.011. Epub 2008 Mar 6.

PMID:
18328674
Items per page

Supplemental Content

Write to the Help Desk